Liver transplantation (LT) is the standard treatment for hepatocellular carcinoma (HCC) and end-stage liver disease, with excellent long-term outcomes despite the increasing use of extended criteria donors due to organ shortage. As traditional evaluation criteria have become insufficient, new indicators such as Arterial and Biliary Complication-Free Survival (ABCFS) have been developed to better assess post-transplant outcomes.
Primary objective: To assess, in a large-scale study, whether the procurement technique influences liver transplantation outcomes in terms of arterial and biliary complication-free survival.
Patients aged 18 years or older at the time of inclusion
Listed on the national waiting list of the Agence de la Biomédecine (ABM)
Undergoing a first liver transplantation in France
Receiving a whole liver graft
Pancreas procurement
Multiorgan transplantation
Split liver transplantation (shared grafts)
Retransplantation
adult patients (≥18 years) who undergo a first liver transplantation in France.
Cohort
Prospective
Not listed
Arterial and Biliary Complication-Free Survival (ABCFS) at 3 years
Postoperative complications at 90 days
Type of Biliary complications
Type of Arterial complications
Occurrence of vascular injuries observed following organ procurement
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
